Brief: Xbrane, STADA Partner With Valorum To Commercialize Ranibizumab Biosimilar Candidate In US
10/05/2024 07:16
May 10 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* XBRANE AND STADA PARTNER WITH VALORUM BIOLOGICS TO
COMMERCIALIZE
RANIBIZUMAB BIOSIMILAR CANDIDATE IN THE US
Source text for Eikon: ID:nMFN7qD4lQ
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))